Galderma North America
在场
Galderma North America 的所有者是 EQT.
是其中之一......
EQT 是一家在股票代码 EQT (SE) 下上市的公司。
EQT 在 14 个国家有直接业务。EQT 拥有 44家子公司，其中包括 Acumatica、Anticimex 和 Atos Medical。
他们在：
涉及EQT的并购和融资。
- EQT 已收购 Perficient (公布2024十月3号).
- WSO2 and EQT have announced they will merge (公布2024八月19号)..
- EQT has announced the acquisition of Perficient (公布2024五月8号).
- EQT has announced the acquisition of WSO2 (公布2024五月7号).
- EQT 已收购 Radius Global Infrastructure (公布2023九月22号).
- EQT has announced the acquisition of Dechra Pharmaceuticals (公布2023六月7号).
- EQT has announced the acquisition of Radius Global Infrastructure (公布2023三月2号).
- 查看更多"EQT"相关新闻 Hide news involving EQT
高管
查看带有其 6 名主要高管的组织结构图
Galderma North America 搜索最多的简介
- Kristen Slaoui, Chief Corporate Development Officer
- Anthony Pansy, Vice President and General Manager, Medical Dermato...
- Ben Foulk, Head of Human Resources
高管在EQT变化
- Anita Davis已作为Managing Director, Corporate Communications and Head of Asia Pacific Corporate Communications加入公司 (新闻发布的2024八月20号).
- Richa Goswami已作为Director加入公司 (新闻发布的2024五月29号).
- Johan Forssell, Director, 已经离开公司 (新闻发布的2024五月29号).
创建提醒
跟踪 Galderma North America 的高管变动
生物技术
EQT 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Galderma North America 的最新新闻稿
- Newsroom
- Galderma Celebrates Self-Expression at Miami Art Week 2022
- GALDERMA LAUNCHES NOVEL FORMULATION WITH ALASTIN SKINCARE® A-LUMINATE BRIGHTENING SERUM® DEVELOPED TO DIMINISH THE APPEARANCE OF HYPERPIGMENTATION
- New data from Galderma's aesthetics portfolio to be presented at 2022 ASDS Annual Meeting
- Galderma and National Breast Cancer Foundation Announce Continued Partnership to Launch Campaign Elevating Skin Stories of Breast Cancer Survivors
- Cetaphil® Celebrates 75 Years of Sensitive Skincare Leadership
- Galderma and Children’s Skin Disease Foundation Celebrate Decade-Long Partnership
- Galderma to present new findings from innovative product portfolio at the 2022 VCS Annual Symposium
- Galderma Launches EPSOLAY® Cream, a Medical Advance to Treat Bumps and Blemishes of Rosacea
- Galderma to highlight latest science and innovation across its product portfolio at the 2022 AAD Annual meeting
- View more press releases Close
通过电子邮件
